OpenURL Connection Search

Select item for more details and to access through your institution.

Radioimmunotherapy: An Underutilized Alternative.
Published in:
Oncology (08909091), 2007, v. 21, n. 2, p. 214
By:
- Kaminski, Mark S.
Publication type:
Article
Factors Predicting Survival in Adults with Stage I and II Large-Cell Lymphoma Treated with Primary Radiation Therapy.
Published in:
Annals of Internal Medicine, 1986, v. 104, n. 6, p. 747, doi. 10.7326/0003-4819-104-6-747
By:
- Kaminski, Mark S.;
- Coleman, Norman;
- Colby, Thomas V.;
- Cox, Richard S.;
- Rosenberg, Saul A.
Publication type:
Article
Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.
Published in:
British Journal of Haematology, 2019, v. 186, n. 2, p. 255, doi. 10.1111/bjh.15923
By:
- Geer, Marcus;
- Roberts, Emily;
- Shango, Maryann;
- Till, Brian G.;
- Smith, Stephen D.;
- Abbas, Hashim;
- Hill, Brian T.;
- Kaplan, Jason;
- Barr, Paul M.;
- Caimi, Paolo;
- Stephens, Deborah M.;
- Lin, Emily;
- Herrera, Alex F.;
- Rosenbaum, Evan;
- Amengual, Jennifer E.;
- Boonstra, Philip S.;
- Devata, Sumana;
- Wilcox, Ryan A.;
- Kaminski, Mark S.;
- Phillips, Tycel J.
Publication type:
Article
R- CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma ( DLBCL): SWOG S0433.
Published in:
British Journal of Haematology, 2014, v. 166, n. 3, p. 382, doi. 10.1111/bjh.12906
By:
- Friedberg, Jonathan W.;
- Unger, Joseph M.;
- Burack, W. Richard;
- Gopal, Ajay K.;
- Raju, Robert N.;
- Nademanee, Auayporn P.;
- Kaminski, Mark S.;
- Li, Hongli;
- Press, Oliver W.;
- Miller, Thomas P.;
- Fisher, Richard I.
Publication type:
Article
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Published in:
British Journal of Haematology, 2014, v. 165, n. 4, p. 510, doi. 10.1111/bjh.12780
By:
- Wang, Michael;
- Popplewell, Leslie L.;
- Collins, Robert H.;
- Winter, Jane N.;
- Goy, Andre;
- Kaminski, Mark S.;
- Bartlett, Nancy L.;
- Johnston, Patrick B.;
- Lister, John;
- Fanning, Suzanne R.;
- Tuscano, Joseph M.;
- Beck, J. Thaddeus;
- Kaya, Hakan;
- Robeva, Anna;
- Fan, Jenna;
- Klimovsky, Judith;
- Cheung, Wing;
- Cherfi, Azzeddine;
- O'Connor, Owen A.
Publication type:
Article
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
Published in:
British Journal of Haematology, 2013, v. 163, n. 4, p. 487, doi. 10.1111/bjh.12570
By:
- Ban‐Hoefen, Makiko;
- Vanderplas, Ann;
- Crosby‐Thompson, Allison L.;
- Abel, Gregory A.;
- Czuczman, Myron S.;
- Gordon, Leo I.;
- Kaminski, Mark S.;
- Kelly, Jennifer;
- Millenson, Michael;
- Nademanee, Auayporn P.;
- Rodriguez, Maria A.;
- Zelenetz, Andrew D.;
- Niland, Joyce;
- LaCasce, Ann S.;
- Friedberg, Jonathan W.
Publication type:
Article
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.
Published in:
Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 601, doi. 10.1177/10781552221075224
By:
- Runge, John S.;
- Brown, Anna B.;
- Phillips, Tycel J.;
- Kaminski, Mark S.;
- Carty, Shannon A.;
- Wilcox, Ryan A.
Publication type:
Article
Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma.
Published in:
Cancer (0008543X), 1997, v. 80, n. S12, p. 2538, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2538::AID-CNCR28>3.0.CO;2-C
By:
- Koral, Kenneth F.;
- Lin, Shuhong;
- Fessler, Jeffrey A.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Acute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesions.
Published in:
European Journal of Haematology, 2002, v. 68, n. 6, p. 392, doi. 10.1034/j.1600-0609.2002.02715.x
By:
- Muler, Jeffrey H.;
- Valdez, Riccardo;
- Hayes, Curtis;
- Kaminski, Mark S.
Publication type:
Article
Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy.
Published in:
Cancer (0008543X), 2002, v. 94, n. S4, p. 1258, doi. 10.1002/cncr.10294
By:
- Koral, Kenneth F.;
- Francis, Isaac R.;
- Kroll, Stewart;
- Zasadny, Kenneth R.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR.
Published in:
2019
By:
- Fangyang Wang;
- Gatica, Damián;
- Zhang Xiao Ying;
- Peterson, Luke F.;
- Kim, Peter;
- Bernard, Denzil;
- Saiya-Cork, Kamlai;
- Shaomeng Wang;
- Kaminski, Mark S.;
- Chang, Alfred E.;
- Phillips, Tycel;
- Klionsky, Daniel J.;
- Malek, Sami N.;
- Wang, Fangyang;
- Ying, Zhang Xiao;
- Kim, Peter K;
- Wang, Shaomeng
Publication type:
journal article
Bio-effect model applied to I radioimmunotherapy of refractory non-Hodgkin's lymphoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 5, p. 874, doi. 10.1007/s00259-010-1699-3
By:
- Roberson, Peter L.;
- Amro, Hanan;
- Wilderman, Scott J.;
- Avram, Anca M.;
- Kaminski, Mark S.;
- Schipper, Matthew J.;
- Dewaraja, Yuni K.
Publication type:
Article
Fetal Dose from PET and CT in Pregnant Patients.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 312, doi. 10.2967/jnumed.122.263959
By:
- Burton, Christiane Sarah;
- Frey, Kirk;
- Fahey, Frederic;
- Kaminski, Mark S.;
- Brown, Richard K. J.;
- Pohlen, Judith M.;
- Shulkin, Barry L.
Publication type:
Article
Fetal Dose from Positron Emission Tomography and Computed Tomography in Pregnant Patients.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263959
By:
- Burton, Christiane Sarah;
- Frey, Kirk;
- Fahey, Frederic;
- Kaminski, Mark S.;
- Brown, Richard K. J.;
- Pohlen, Judith M.;
- Shulkin, Barry L.
Publication type:
Article
Fetal Dose from Positron Emission Tomography and Computed Tomography in Pregnant Patients.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263959
By:
- Burtona, Christiane Sarah;
- Frey, Kirk;
- Fahey, Frederic;
- Kaminski, Mark S.;
- Brown, Richard K. J.;
- Pohlen, Judith M.;
- Shulkin, Barry L.
Publication type:
Article
Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1800, doi. 10.2967/jnumed.115.156190
By:
- Wahl, Richard L.;
- Horner, Thierry J.;
- Lin, Thomas S.;
- Kaminski, Mark S.
Publication type:
Article
Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy.
Published in:
Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1047, doi. 10.2967/jnumed.113.136044
By:
- Dewaraja, Yuni K.;
- Schipper, Matthew J.;
- Jincheng Shen;
- Smith, Lauren B.;
- Murgic, Jure;
- Savas, Hatice;
- Youssef, Ehab;
- Regan, Denise;
- Wilderman, Scott J.;
- Roberson, Peter L.;
- Kaminski, Mark S.;
- Avram, Anca M.
Publication type:
Article
131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling.
Published in:
Journal of Nuclear Medicine, 2010, v. 51, n. 7, p. 1155, doi. 10.2967/jnumed.110.075176
By:
- Dewaraja, Yuni K.;
- Schipper, Matthew J.;
- Roberson, Peter L.;
- Wilderman, Scott J.;
- Amro, Hanan;
- Regan, Denise D.;
- Koral, Kenneth F.;
- Kaminski, Mark S.;
- Avram, Anca M.
Publication type:
Article
Survival following salvage therapy for primary refractory peripheral T‐cell lymphomas (PTCL).
Published in:
American Journal of Hematology, 2018, v. 93, n. 3, p. 394, doi. 10.1002/ajh.24992
By:
- Zhang, Janie Y.;
- Briski, Robert;
- Devata, Sumana;
- Kaminski, Mark S.;
- Phillips, Tycel J.;
- Mayer, Tera L.;
- Bailey, Nathanael G.;
- Wilcox, Ryan A.
Publication type:
Article
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
Published in:
American Journal of Hematology, 2017, v. 92, n. 12, p. 1287, doi. 10.1002/ajh.24895
By:
- Boonstra, Philip S.;
- Polk, Avery;
- Brown, Noah;
- Hristov, Alexandra C.;
- Bailey, Nathanael G.;
- Kaminski, Mark S.;
- Phillips, Tycel;
- Devata, Sumana;
- Mayer, Tera;
- Wilcox, Ryan A.
Publication type:
Article
A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome.
Published in:
American Journal of Hematology, 2016, v. 91, n. 12, p. E491, doi. 10.1002/ajh.24564
By:
- Hanel, Walter;
- Briski, Robert;
- Ross, Charles W.;
- Anderson, Thomas F.;
- Kaminski, Mark S.;
- Hristov, Alexandra C.;
- Wilcox, Ryan A
Publication type:
Article
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Published in:
Cancer (0008543X), 2014, v. 120, n. 13, p. 1993, doi. 10.1002/cncr.28676
By:
- Herrera, Alex F.;
- Crosby‐Thompson, Allison;
- Friedberg, Jonathan W.;
- Abel, Gregory A.;
- Czuczman, Myron S.;
- Gordon, Leo I.;
- Kaminski, Mark S.;
- Millenson, Michael M.;
- Nademanee, Auayporn P.;
- Niland, Joyce C.;
- Rodig, Scott J.;
- Rodriguez, Maria A.;
- Zelenetz, Andrew D.;
- LaCasce, Ann S.
Publication type:
Article
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project.
Published in:
2013
By:
- Evens, Andrew M;
- Vanderplas, Ann;
- Lacasce, Ann S;
- Crosby, Allison L;
- Nademanee, Auayporn P;
- Kaminski, Mark S;
- Abel, Gregory A;
- Millenson, Michael;
- Czuczman, Myron S;
- Rodriguez, Maria A;
- Niland, Joyce;
- Zelenetz, Andrew D;
- Gordon, Leo I;
- Friedberg, Jonathan W
Publication type:
Journal Article
Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab.
Published in:
Cancer (0008543X), 2013, v. 119, n. 20, p. 3662, doi. 10.1002/cncr.28243
By:
- Evens, Andrew M.;
- Vanderplas, Ann;
- LaCasce, Ann S.;
- Crosby, Allison L.;
- Nademanee, Auayporn P.;
- Kaminski, Mark S.;
- Abel, Gregory A.;
- Millenson, Michael;
- Czuczman, Myron S.;
- Rodriguez, Maria A.;
- Niland, Joyce;
- Zelenetz, Andrew D.;
- Gordon, Leo I.;
- Friedberg, Jonathan W.
Publication type:
Article
Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.
Published in:
2017
By:
- Moinpour, Carol;
- Unger, Joseph;
- Ganz, Patricia;
- Kornblith, Alice;
- Gaynor, Ellen;
- Bowers, Mindy;
- Gatti, Gretchen;
- Kaminski, Mark S.;
- Erba, Harry;
- Wang, Ting;
- Yoon, Jihye;
- Press, Oliver;
- Fisher, Richard;
- Moinpour, Carol M;
- Unger, Joseph M;
- Ganz, Patricia A;
- Kornblith, Alice B;
- Gaynor, Ellen R;
- Bowers, Mindy Ann;
- Gatti, Gretchen S
Publication type:
journal article
Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.
Published in:
OncoTargets & Therapy, 2019, v. 12, p. 8003, doi. 10.2147/OTT.S155778
By:
- Girard, Jennifer;
- Reneau, John;
- Devata, Sumana;
- Wilcox, Ryan A;
- Kaminski, Mark S;
- Mercer, Jessica;
- Carty, Shannon;
- Phillips, Tycel J
Publication type:
Article
Correlation of Tumor Radiation-Absorbed Dose with Response Is Easier to Find in Previously Untreated Patients.
Published in:
Journal of Nuclear Medicine, 2003, v. 44, n. 9, p. 1541
By:
- Koral, Kenneth F.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Update on Hybrid Conjugate-View SPECT Tumor Dosimetry and Response in 131I-Tositumomab Therapy of Previously Untreated Lymphoma Patients.
Published in:
Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 457
By:
- Koral, Kenneth F.;
- Dewaraja, Yuni;
- Jia Li;
- Qiang Lin;
- Regan, Denise D.;
- Zasadny, Kenneth R.;
- Rommelfanger, Stephen G.;
- Francis, Issac R.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
A Practical Methodology for Patient Release After Tositumomab and 131I-Tositumomab Therapy.
Published in:
Journal of Nuclear Medicine, 2002, v. 43, n. 3, p. 354
By:
- Siegel, Jeffry A.;
- Kroll, Stewart;
- Regan, Denise;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Initial Results for Hybrid SPECT--Conjugate-View Tumor Dosimetry in 131I-Anti-B1 Antibody Therapy of Previously Untreated Patients with Lymphoma,.
Published in:
Journal of Nuclear Medicine, 2000, v. 41, n. 9, p. 1579
By:
- Koral, Kenneth F.;
- Dewaraja, Yuni;
- Jia Li;
- Barrett, Carla L.;
- Regan, Denise D.;
- Zasadny, Kenneth R.;
- Rommelfanger, Stephen G.;
- Francis, Issac R.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Metabolic Response of Non-Hodgkin's Lymphoma to 131I-Anti-B1 Radioimmunotherapy: Evaluation with FDG PET.
Published in:
Journal of Nuclear Medicine, 2000, v. 41, n. 6, p. 999
By:
- Torizuka, Tatsuo;
- Zasadny, Kenneth R.;
- Kison, Paul V.;
- Rommelfanger, Stephen G.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
Nonmyeloablative Iodine-131 Anti-B1 Radioimmunotherapy as Outpatient Therapy.
Published in:
Journal of Nuclear Medicine, 1998, v. 39, n. 7, p. 1230
By:
- Gates, Vanessa L.;
- Carey, James E.;
- Siegel, Jeffry A.;
- Kaminski, Mark S.;
- Wahl, Richard L.
Publication type:
Article
CT-SPECT Fusion Plus Conjugate Views for Determining Dosimetry in Iodine-131-Monoclonal Antibody Therapy of Lymphoma Patients.
Published in:
Journal of Nuclear Medicine, 1994, v. 35, n. 10, p. 1714
By:
- Koral, Kenneth F.;
- Zasadny, Kenneth R.;
- Kessler, Marc L.;
- Jian-Qiao Luo;
- Buchbinder, Steven F.;
- Kaminski, Mark S.;
- Francis, Isaac;
- Wahl, Richard L.
Publication type:
Article
Importance of the Terminal Portion of Tumor Time-Activity Curve in Determining Tumor Dosimetry in Radioimmunotherapy.
Published in:
Journal of Nuclear Medicine, 1991, v. 32, n. 6, p. 1314
By:
- Wahl, Richard L.;
- Zasadny, Kenneth;
- Kaminski, Mark S.
Publication type:
Article
The Potential of 2-Deoxy-2[18F]Fluoro-D-Glucose (FDG) for the Detection of Tumor Involvement in Lymph Nodes.
Published in:
Journal of Nuclear Medicine, 1990, v. 31, n. 11, p. 1831
By:
- Wahl, Richard L.;
- Kaminski, Mark S.;
- Ethier, Stephen P.;
- Hutchins, Gary D.
Publication type:
Article
Isotype Switch Variant Anti-Idiotype Monoclonal Antibodies: Comparative Radiolabeling and In Vitro Binding.
Published in:
Journal of Nuclear Medicine, 1989, v. 30, n. 2, p. 227
By:
- Wahl, Richard L.;
- Wissing, Joseph R.;
- Kaminski, Mark S.
Publication type:
Article

Found: 36

Radioimmunotherapy: An Underutilized Alternative.

Factors Predicting Survival in Adults with Stage I and II Large-Cell Lymphoma Treated with Primary Radiation Therapy.

Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.

R- CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma ( DLBCL): SWOG S0433.

Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.

Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.

The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.

Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma.

Acute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesions.

Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy.

Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR.

Bio-effect model applied to I radioimmunotherapy of refractory non-Hodgkin's lymphoma.

Fetal Dose from PET and CT in Pregnant Patients.

Fetal Dose from Positron Emission Tomography and Computed Tomography in Pregnant Patients.

Fetal Dose from Positron Emission Tomography and Computed Tomography in Pregnant Patients.

Observational Retrospective Study of Altered Biodistribution of Tositumomab and <sup>131</sup>I-Tositumomab.

Tumor-Absorbed Dose Predicts Progression-Free Survival Following <sup>131</sup>I-Tositumomab Radioimmunotherapy.

<sup>131</sup>I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling.

Survival following salvage therapy for primary refractory peripheral T‐cell lymphomas (PTCL).

A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.

A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome.

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project.

Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab.

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.

Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.

Correlation of Tumor Radiation-Absorbed Dose with Response Is Easier to Find in Previously Untreated Patients.

Update on Hybrid Conjugate-View SPECT Tumor Dosimetry and Response in <sup>131</sup>I-Tositumomab Therapy of Previously Untreated Lymphoma Patients.

A Practical Methodology for Patient Release After Tositumomab and <sup>131</sup>I-Tositumomab Therapy.

Initial Results for Hybrid SPECT--Conjugate-View Tumor Dosimetry in <sup>131</sup>I-Anti-B1 Antibody Therapy of Previously Untreated Patients with Lymphoma,.

Metabolic Response of Non-Hodgkin's Lymphoma to <sup>131</sup>I-Anti-B1 Radioimmunotherapy: Evaluation with FDG PET.

Nonmyeloablative Iodine-131 Anti-B1 Radioimmunotherapy as Outpatient Therapy.

CT-SPECT Fusion Plus Conjugate Views for Determining Dosimetry in Iodine-131-Monoclonal Antibody Therapy of Lymphoma Patients.

Importance of the Terminal Portion of Tumor Time-Activity Curve in Determining Tumor Dosimetry in Radioimmunotherapy.

The Potential of 2-Deoxy-2[<sup>18</sup>F]Fluoro-D-Glucose (FDG) for the Detection of Tumor Involvement in Lymph Nodes.

Isotype Switch Variant Anti-Idiotype Monoclonal Antibodies: Comparative Radiolabeling and In Vitro Binding.